Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 400-320-4 | CAS number: 94933-05-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From Oct. to Nov. 1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1984
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 1981
- Deviations:
- yes
- Remarks:
- scale for skin reactions differs from protocol; 10 control animals used instead of 20; test animal age not specified
- GLP compliance:
- no
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- An in vitro or in chemico skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study (different from LLNA test) is available.
Test material
- Reference substance name:
- -
- EC Number:
- 400-320-4
- EC Name:
- -
- Cas Number:
- 94933-05-8
- Molecular formula:
- not applicable
- IUPAC Name:
- chromium(3+) trisodium bis(2-(2-{4-hydroxy-2-oxido-3-[2-(5-sulfonatonaphthalen-1-yl)diazen-1-yl]phenyl}diazen-1-yl)benzoate)
- Test material form:
- solid: particulate/powder
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Remarks:
- Hartley-Dunkin
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Hacking and Churchill Ltd., Abbots Ripton Road, Wyton, Huntingdon, PE17 2DT, England
- Females nulliparous and non-pregnant: not specified
- Microbiological status of animals: not specified
- Age at study initiation: not specified
- Weight at study initiation: 291 to 328 g
- Housing: groups of one or two guinea pigs by dose group, in grid floor polypropylene cages
- Diet: ad libitum; Guinea Pig Diet, Standard with Vitamin C (Special Diets Services Ltd., Stepfield, Witham, Essex, England)
- Water: ad libitum ; certificate to demonstrate the quality of the drinking water of Yorkshire Water Authorityn provided
- Acclimation period: 5 days
- Indication of any skin lesions: not specified
- Randomisation: no formal randomisation procedure; transferred upon arrival in order of left to right
- Identification: indelible ink markings on the ears (Inscribe 700, Inscribe Ltd., Alton, Hants, England)
ENVIRONMENTAL CONDITIONS
- Temperature: 18 to 23 °C
- Humidity: 49 to 74 %
- Air changes: not specified
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- water
- Remarks:
- distilled
- Concentration / amount:
- 5.0 % (w/v)
- Day(s)/duration:
- one pair of injections
- Route:
- intradermal
- Vehicle:
- other: Complete adjuvant 50:50 v/v in water
- Concentration / amount:
- 0 % (w/v)
- Day(s)/duration:
- one pair of injections
- Route:
- intradermal
- Vehicle:
- other: Complete adjuvant 50:50 v/v in water
- Concentration / amount:
- 5.0 % (w/v)
- Day(s)/duration:
- one pair of injections
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Remarks:
- distilled
- Concentration / amount:
- 25 % (w/v)
- Day(s)/duration:
- 48 hours
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Remarks:
- distilled
- Concentration / amount:
- 25 % (w/v)
- Day(s)/duration:
- 24 hours
- No. of animals per dose:
- Test group: 20 guinea pigs (10 male and 10 female)
Control group: 10 guinea pigs (5 male and 5 female) - Details on study design:
- RANGE FINDING TESTS: previous experience with the test item indicated that it was non-irritant by topical application. No screening study was considered necessary and concentrations of 5.0 % w/v in distilled water and adjuvant and 25 % w/v in distilled water were selected for the intradermal injections and the topical induction and challenge applications.
MAIN STUDY
A. INDUCTION EXPOSURE
I) Induction by intradermal injection: 3 pairs of 1.0 ml injections were administered to the clipped shoulder region of 20 test animals and 10 control animals using 26 gauge sterile hypodermic needles attached to a 1 ml disposable plastic syringe.
- No. of exposures: 3 pairs of 1.0 ml injections
- Test groups: 20 guinea pigs (10 male and 10 female)
- Control group: 10 guinea pigs (5 male and 5 female)
- Site: 4 x 6 cm clipped area on the shoulder region
- Frequency of applications: singluar injections
- Test concentrations: 1st pair: 5.0 % test item in distilled water; 2nd pair: complete adjuvant (50 % v/v in water); 3rd pair: 5.0 % test item emulsified in 50 % v/v complete adjuvant
- Control concentrations: 1st pair: distilled water; 2nd pair: complete adjuvant (50 % v/v in water); 3rd pair: complete adjuvant (50 % v/v in water)
- Duration: day 1
II) Induction by topical application: one week after the induction by intradermal injection, the same area was re-clipped and a 2 x 4 cm patch of Whatman no. 3 mm filter paper saturated in 25 % w/v test item was applied to the area, and secured with overlapping occlusive tape for 48 hours (control group administered vehicle only).
- No. of exposures: 1
- Exposure period: 48 hours
- Test groups: 20 guinea pigs (10 male and 10 female)
- Control group: 10 guinea pigs (5 male and 5 female)
- Site: 4 x 6 cm clipped area on the shoulder region
- Frequency of applications: once
- Concentration: 25 % (test group)
- Duration: days 8 to 10
B. CHALLENGE EXPOSURE
Challenge by topical application: a 5 x 5 cm area was clipped on both the right and left flanks of test and control animals. A 2 x 2 cm filter paper pad saturated in 25 % w/v test item in distilled water was applied to the left flank of all animals and secured with overlapping occlusive tape for 24 hours. A similar pad saturated in distilled water was applied similarly to the right flank of all animals.
- No. of exposures: 1
- Duration: two weeks after induction by topical application
- Exposure period: 24 hours
- Test groups: 20 guinea pigs (10 male and 10 female)
- Control group: 10 guinea pigs (5 male and 5 female)
- Site: left and right flanks
- Concentrations: 25 % w/v in distilled water and 0 % in distilled water (all animals)
- Evaluation: 24 and 48 hours after the removal of the dressing
- Challenge controls:
- Induction by injection: vehicle only
Induction by topical application: treated the same as test animals
Challenge: treated the same as test animals - Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Test challenge (25 % w/v test item in distilled water; left flank)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Test challenge (25 % w/v test item in distilled water; left flank)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Vehicle challenge (0 % test item in distilled water; right flank)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Vehicle challenge (0 % test item in distilled water; right flank)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Test challenge (25 % w/v test item in distilled water; left flank)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- Test challenge (25 % w/v test item in distilled water; left flank)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Vehicle challenge (0 % test item in distilled water; right flank)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- Vehicle challenge (0 % test item in distilled water; right flank)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Group:
- positive control
- Remarks on result:
- not measured/tested
Any other information on results incl. tables
Table 1: Results summary.
Observation time | Number showing response at challenge (%) | Classification | |||
Test | Control | ||||
L | R | L | R | ||
24 | 0/20(0) | 0/20(0) | 0/10(0) | 0/10(0) | non-sensitiser |
48 | 0/20(0) | 0/20(0) | 0/10(0) | 0/10(0) |
L = left flank - test challenge site
R = right flank = vehicle challenge site
Table 2: Skin reactions in test animals following challenge application of the test item.
Animal number | Gender | Weight (g) | Skin reactions | |||
24 | 48 | |||||
L | R | L | R | |||
1 | M | 315 | 0 | 0 | 0 | 0 |
2 | 313 | 0 | 0 | 0 | 0 | |
3 | 311 | 0 | 0 | 0 | 0 | |
4 | 315 | 0 | 0 | 0 | 0 | |
5 | 318 | 0 | 0 | 0 | 0 | |
6 | 292 | 0 | 0 | 0 | 0 | |
7 | 304 | 0 | 0 | 0 | 0 | |
8 | 291 | 0 | 0 | 0 | 0 | |
9 | 292 | 0 | 0 | 0 | 0 | |
10 | 296 | 0 | 0 | 0 | 0 | |
11 | F | 315 | 0 | 0 | 0 | 0 |
12 | 313 | 0 | 0 | 0 | 0 | |
13 | 311 | 0 | 0 | 0 | 0 | |
14 | 322 | 0 | 0 | 0 | 0 | |
15 | 311 | 0 | 0 | 0 | 0 | |
16 | 324 | 0 | 0 | 0 | 0 | |
17 | 308 | 0 | 0 | 0 | 0 | |
18 | 307 | 0 | 0 | 0 | 0 | |
19 | 307 | 0 | 0 | 0 | 0 | |
20 | 293 | 0 | 0 | 0 | 0 |
L = left flank - test challenge site
R = right flank = vehicle challenge site
Table 3: Skin reactions in control animals following challenge application of the test item.
Animal number | Gender | Weight (g) | Skin reactions | |||
24 | 48 | |||||
L | R | L | R | |||
21 | M | 291 | 0 | 0 | 0 | 0 |
22 | 311 | 0 | 0 | 0 | 0 | |
23 | 328 | 0 | 0 | 0 | 0 | |
24 | 310 | 0 | 0 | 0 | 0 | |
25 | 300 | 0 | 0 | 0 | 0 | |
26 | F | 305 | 0 | 0 | 0 | 0 |
27 | 312 | 0 | 0 | 0 | 0 | |
28 | 315 | 0 | 0 | 0 | 0 | |
29 | 318 | 0 | 0 | 0 | 0 | |
30 | 295 | 0 | 0 | 0 | 0 |
L = left flank - test challenge site
R = right flank = vehicle challenge site
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified according to the CLP Regulation (EC 1272/2008)
- Conclusions:
- The substance was not found to be a sensitiser under the test conditions.
- Executive summary:
Skin sensitisation potential was evaluated in an experimental study according to the Guinea Pig Maximisation Test (GPMT), comparable to the OECD Guideline 406 (1981). A separate, preliminary study found that the test item was non-irritant to skin, so the following test concentrations were determined as appropriate: 5.0 % (w/v) in distilled water and in adjuvant for induction by intradermal injection; and 25 % (w/v) in distilled water for induction by topical induction and for the challenge applications.
Induction: 10 male and 10 female guinea pigs were administered 3 pairs of 0.1 ml intradermal injections along the side of a 4 x 6 cm area on the clipped shoulder region. The three pairs of injections contained the following: 1. 0.1 ml 5.0 % (w/v) test item in distilled water; 2. 0.1 ml Complete adjuvant (50 % v/v in water); 3. 0.1 ml 5.0 % (w/v) test item emulsified in 50 % (v/v) Complete adjuvant. An additional 5 male and 5 female control guinea pigs were administered three pairs of injections containing: 1. 0.1 ml distilled water; 2. 0.1 ml Complete Adjuvant (50 % (v/v) in water); 3. 0.1 ml Complete Adjuvant (50 % (v/v) in water. One week later, the same region was re-clipped and a 2 x 4 cm patch of Whatman No. 3 filter paper, saturated in 25 % (w/v) test item (test group) or vehicle (control group), was secured using overlapping occlusive tape for 48 hours.
Challenge: Two weeks later, the flanks of test and control animals were clipped (5 x 5 cm area). 2 x 2 cm patch of filter paper saturated with 25 % test item was applied to the left flank, and another saturated with distilled water to the right flank, with overlapping occlusive tape for 24 hours, at which time the dressing was removed. Skin reactions were recorded 24 and 48 hours after the dressing was removed.
No skin reactions were recorded in either test or control groups during the study period, at either 24 or 48 hours after treatment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.